RE:Resverlogix Provides Update on BETonMACE Phase 3 Trial
fantastic news, long overdue! gonna b a nail biter until the end of the month eh?
quick question for the brain-trust: what to make of the presentation schedule?
i'll add some bolding cause something jumps out to me:
from the NR: "expect that BETonMACE’s full outcomes, pre-specified endpoint data, safety results and clinical implications will be reported and published through major conferences and publications in late-2019 and afterward beginning with the American Heart Association (AHA) meeting in November 2019 in Philadelphia, followed by the Clinical trial on Alzheimer’s Disease (CtAD) meeting in December 2019 in San Diego. Data will also be disseminated at leading nephrology meetings."
very specific. am i to believe that we have landed the late breaking session at AHA then!? to be announced this week? that hasn't been announced yet, and over at agora BDaz posted a link to some tweets for last week and early this week, so we're waiting for that?
BUT... they have something on the books for CTAD in Dec San Diego?
Guess nothing for ASN Kidney week conference Nov 6-10?
And nothing for CTAD Asia Oct 11-12?
I like the AHA placeholder, and the AD placeholder, where is the placeholder for Renal!?
Go RVX go!!!!